Trial · NCT01139658
Results by group54
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 54
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Occurrence of Symptomatic Venous Thromboembolic Events | Total Knee Replacement | 19 | participants | ||
| Occurrence of Symptomatic Venous Thromboembolic Events | Total Hip Replacement | 5 | participants | ||
| Occurrence of Major Bleeding Events | Total Knee Replacement | 8 | participants | ||
| Occurrence of Major Bleeding Events | Total Hip Replacement | 16 | participants | ||
| Dosage of Pradaxa at Initiation | Total Knee Replacement | 75 mg/day | 142 | participants | |
| Dosage of Pradaxa at Initiation | Total Hip Replacement | 75 mg/day | 162 | participants | |
| Dosage of Pradaxa at Initiation | Total Knee Replacement | 110 mg/day | 394 | participants | |
| Dosage of Pradaxa at Initiation | Total Hip Replacement | 110 mg/day | 417 | participants | |
| Dosage of Pradaxa at Initiation | Total Knee Replacement | 150 mg/day | 80 | participants | |
| Dosage of Pradaxa at Initiation | Total Hip Replacement | 150 mg/day | 122 | participants | |
| Dosage of Pradaxa at Initiation | Total Knee Replacement | 220mg/day | 130 | participants | |
| Dosage of Pradaxa at Initiation | Total Hip Replacement | 220mg/day | 228 | participants | |
| Duration Between Surgery and First Dose of Pradaxa | Total Knee Replacement | 12.6 | Standard Deviation 14.5 | hours | |
| Duration Between Surgery and First Dose of Pradaxa | Total Hip Replacement | 14.6 | Standard Deviation 16.8 | hours | |
| Duration of Treatment | Total Knee Replacement | 27.5 | Standard Deviation 11.8 | days | |
| Duration of Treatment | Total Hip Replacement | 33.3 | Standard Deviation 10.4 | days | |
| Proportion of Patients With a Preoperative ALT Measurement | Total Knee Replacement | 73.3 | percentage of participants | ||
| Proportion of Patients With a Preoperative ALT Measurement | Total Hip Replacement | 74.5 | percentage of participants | ||
| Adherence to Treatment | Total Knee Replacement | 98.6 | Standard Deviation 24.6 | percent | |
| Adherence to Treatment | Total Hip Replacement | 97.3 | Standard Deviation 24.6 | percent |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01139658/results